TMCI (Treace Medical Concepts) Total Operating Expense: $216.8 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TMCI Treace Medical Concepts Inc TMCI
68 GF Score
Price $4.79
GF Value $6.35
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Treace Medical Concepts Total Operating Expense?

Treace Medical Concepts TMCI +6.21% 68 Total Operating Expense is $216.8 Mil as of Jun. 2026. GuruFocus rates TMCI with a GF Score™ of 68/100 and a GF Value™ of $6.35 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Treace Medical Concepts's Total Operating Expense for the three months ended in Jun. 2026 was $50.6 Mil. Treace Medical Concepts's Total Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 was $216.8 Mil.

Treace Medical Concepts Total Operating Expense Related Terms

Treace Medical Concepts Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Treace Medical Concepts's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Treace Medical Concepts Total Operating Expense Chart

Treace Medical Concepts Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial 94.04 151.15 203.37 223.95 223.91

Treace Medical Concepts Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 54.73 55.38 56.32 54.57 50.57
TMCI
68GF Score
Treace Medical Concepts Inc TMCI
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Treace Medical Concepts Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $216.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $216.8 Mil mean?
Treace Medical Concepts (TMCI) has a Total Operating Expense of $216.8 Mil as of Jun. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Treace Medical Concepts and its competitors.
Is Treace Medical Concepts' Total Operating Expense too high?
Treace Medical Concepts' current Total Operating Expense is $216.8 Mil. Overall, Treace Medical Concepts has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Treace Medical Concepts' Total Operating Expense compare to TLSI and SENS?
Treace Medical Concepts' Total Operating Expense of $216.8 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Medical Devices & Instruments company?
A good Total Operating Expense depends on the Medical Devices & Instruments industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Treace Medical Concepts and its competitors. Treace Medical Concepts's current Total Operating Expense is $216.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Treace Medical Concepts stock overvalued right now?
Based on GuruFocus' analysis, Treace Medical Concepts (TMCI) is currently considered Modestly Undervalued. The stock's GF Value™ is $6.35, compared to a current price of $4.79 — trading 24.6% below its estimated fair value. The current Total Operating Expense is $216.8 Mil. Treace Medical Concepts' overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Treace Medical Concepts (TMCI), the current Total Operating Expense is $216.8 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Treace Medical Concepts (TMCI) Overvalued in 2026?

Based on GuruFocus' analysis, Treace Medical Concepts stock appears to be undervalued. The current stock price of $4.79 is trading 24.6% below its estimated GF Value™ of $6.35. GuruFocus considers Treace Medical Concepts to be Modestly Undervalued.

Key valuation signals for TMCI:

  • Total Operating Expense: $216.8 Mil
  • GF Value™: $6.35 vs. price of $4.79 (24.6% below fair value)
  • GF Score™: 68/100 with 5 warning signs

No single metric tells the full story. See the TMCI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Treace Medical Concepts Business Description

Address 100 Palmetto Park Place, Ponte Vedra, FL, USA, 32081
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The company operates and manages its business as a single segment: designing, manufacturing, and marketing medical devices for surgeons, ambulatory surgery centers, and hospitals related to the surgical management of bunion and related midfoot deformities.
68GF Score

Get the complete analysis for TMCI

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.79
Price
$6.35
GF Value